UK prepares to offer COVID-19 booster shots from September: Reports

Interim advice from the JCVI is that boosters will help maintain protection against COVID-19 and new variants for those most at risk before winter comes.

PTI
July 01, 2021 / 06:11 PM IST

Source: Reuters

The UK government is preparing to offer millions of vulnerable Britons, who have received two doses of the COVID-19 vaccine, a booster jab from September to ensure that the protection is maintained against new variants of the coronavirus before winter comes, according to media reports.

The National Health Service (NHS) has been given the green light to start planning a Covid vaccine booster programme, the BBC reported.

Health and Social Care Secretary Sajid Javid said ministers were working with the NHS to rapidly deliver the programme from September.

"Our first COVID-19 vaccination programme is restoring freedom in this country, and our booster programme will protect this freedom," he said.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The Department of Health said the plan had been drawn up following advice from the Joint Committee on Vaccination and Immunisation (JCVI) and will take place alongside the annual flu jab rollout, according to the Express newspaper.

Interim advice from the JCVI is that boosters will help maintain protection against COVID-19 and new variants for those most at risk before winter comes.

Vaccines Minister Nadhim Zahawi said: "Our COVID-19 vaccination programme has been a roaring success, with almost 85 percent of adults across the UK receiving a first dose and more than 62 percent getting both doses."

"We are now planning ahead to future-proof this progress and protect our most vulnerable from variants and flu ahead of the winter," he said.

More than 30 million of the most vulnerable should receive a third dose, vaccine experts are advising.

They will include all adults aged 50 and over, and anyone younger who qualifies for a flu jab.

Health service bosses had previously said they needed lots of warning of an autumn Covid-19 booster rollout to plan the logistics alongside vaccinating millions of people against flu, the BBC said.

The vaccines are thought to protect most people against serious illness for at least six months, but a lack of data on exactly how long immunity lasts is prompting a safety-first approach, it said.

No decisions have yet been made on which vaccines will be used.

Prof Jonathan Van-Tam, deputy chief medical officer for England, said: "We want to be on the front foot for COVID-19 booster vaccination to keep the probability of loss of vaccine protection, due to waning immunity or variants, as low as possible - especially over the coming autumn and winter."

He said other respiratory viruses, particularly flu, "will make a comeback" and be an additional problem this winter.

"We will need to ensure protection against flu, as well as maintaining protection against COVID-19," Prof Van-Tam said.

The JCVI''s final advice will be published before September when better data will be available on how long protection from the first two doses of the vaccines lasts.

The latest figures on hospitalisations, emerging variants and trials will also be taken into account at that point, and could change their advice.

The government said that a final decision on whether a vaccine booster campaign was needed had not been made, but officials had advised that preparations should begin on a precautionary basis.

The JCVI advised the programme should take place in two stages, with the first round focusing on frontline health and social care workers, clinically vulnerable people, care home residents and those who are immunosuppressed.

All adults over 70 will also fall into this category.

Once these batches of people have been offered their booster vaccine, the next stage will concentrate on three categories.

These include all adults over 50, adults under 50 who are in high-risk groups and adults living with immunosuppressed individuals.

Prof Wei Shen Lim, COVID-19 chair for JCVI, said all these groups would also be eligible for the annual flu vaccine and were strongly advised to have it.

Younger adults will be not be given a third dose, because they will only have had their second dose in the summer, although this decision will be revisited at a later time, the JCVI said.

The latest data from the Government shows 44.7 million people have received their first dose and 32.8 million are fully inoculated with two jabs.

The UK on Wednesday recorded a further 26,068 cases of COVID-19, the highest daily figure since January 29.

The total number of coronavirus cases in the country now stands at 4,800,907 with 128,140 deaths.

Follow our full coverage of the coronavirus pandemic here.
PTI
TAGS: #coronavirus #COVID-19 vaccine #Health #UK #World News
first published: Jul 1, 2021 06:10 pm